SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Ranbaxy Labs
Ranbaxy Labs
BSE: 500359NSE: RANBAXYISIN: INE015A01028

25th-Feb-2013 11:53Source: BSE

Ranbaxy Labs - Update on Atorvastatin Recall

In Nov 2012, Ranbaxy Pharmaceuticals Inc., the US subsidiary of Ranbaxy, had initiated a voluntary recall for select batches and strengths of Atorvastatin calcium tablets only in the USA. However, Ranbaxy continues to supply this product in other markets across the world.

More Announcements on:

30th-Jul-2014 12:25Source: NSE

Ranbaxy Laboratories Limited

30th-Jul-2014 12:03Source: BSE

Ranbaxy Labs - Updates on Results Press Release

30th-Jul-2014 09:57Source: NSE

Ranbaxy Laboratories Limited

30th-Jul-2014 08:50Source: NSE

Ranbaxy Laboratories Limited

30th-Jul-2014 08:48Source: NSE

Ranbaxy Laboratories Limited

29th-Jul-2014 16:41Source: BSE

Ranbaxy Labs - Limited Review for June 30, 2014

29th-Jul-2014 16:24Source: BSE

Ranbaxy Labs - Results Press Release

29th-Jul-2014 16:21Source: BSE

Ranbaxy Labs - Announces Q1 Results

24th-Jul-2014 19:45Source: NSE

Ranbaxy Laboratories Limited

1 2 3 4 5 Next >>
OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(July 28, 2014)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
3150

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1890

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1890

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.